Corticotropin - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for corticotropin and what is the scope of patent protection?
Corticotropin
is the generic ingredient in seven branded drugs marketed by Parkedale, Sanofi Aventis Us, Mallinckrodt Ard, Organics Lagrange, Watson Labs, and Ani Pharms, and is included in seven NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.There are ten drug master file entries for corticotropin. Two suppliers are listed for this compound.
Summary for corticotropin
US Patents: | 3 |
Tradenames: | 7 |
Applicants: | 6 |
NDAs: | 7 |
Drug Master File Entries: | 10 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 19 |
Clinical Trials: | 57 |
Patent Applications: | 6,827 |
DailyMed Link: | corticotropin at DailyMed |
Recent Clinical Trials for corticotropin
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Rutgers, The State University of New Jersey | Phase 2 |
Yangzhou University | N/A |
Feinstein Institute for Medical Research | Phase 2 |
Pharmacology for corticotropin
Drug Class | Adrenocorticotropic Hormone |
Anatomical Therapeutic Chemical (ATC) Classes for corticotropin
US Patents and Regulatory Information for corticotropin
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mallinckrodt Ard | ACTHAR GEL (AUTOINJECTOR) | corticotropin | INJECTABLE;INJECTION | 008372-004 | Feb 29, 2024 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Ani Pharms | CORTROPHIN-ZINC | corticotropin-zinc hydroxide | INJECTABLE;INJECTION | 009854-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Watson Labs | CORTICOTROPIN | corticotropin | INJECTABLE;INJECTION | 088772-001 | Nov 21, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Ani Pharms | PURIFIED CORTROPHIN GEL | corticotropin | INJECTABLE;INJECTION | 008975-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sanofi Aventis Us | ACTHAR | corticotropin | INJECTABLE;INJECTION | 007504-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.